Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa

Clinical trial NCT04925687 · COMPLETED

Trial details

NCT number: NCT04925687
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2021-06-01
Primary completion: 2023-11-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.